Cleveland, OH, United States of America

Jeremy Rich

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: The Cleveland Clinic Foundation, The University of Texas System, Washington University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy Rich. Retrieved from https://idiyas.com/inventor/jeremy-rich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeremy Rich: Innovator in Glioma Treatment

Introduction

Jeremy Rich is a prominent inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of glioblastoma. His innovative approach utilizes Zika virus strains to combat this aggressive form of brain cancer.

Latest Patents

Jeremy Rich holds 1 patent for his work on Zika virus strains for the treatment of glioma. The patent details a composition and method for treating glioblastoma using the Zika virus, showcasing a novel approach to a challenging medical issue.

Career Highlights

Throughout his career, Jeremy has worked with esteemed institutions such as Washington University and The Cleveland Clinic Foundation. His research has focused on developing new therapeutic strategies for glioblastoma, contributing to advancements in cancer treatment.

Collaborations

Jeremy has collaborated with notable colleagues, including Michael S. Diamond and Milan Chheda. Their combined expertise has furthered the understanding and potential treatment options for glioblastoma.

Conclusion

Jeremy Rich's innovative work in utilizing Zika virus strains for glioma treatment represents a significant advancement in cancer research. His contributions continue to inspire new approaches in the fight against glioblastoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…